First Command Bank’s Novo Nordisk NVO Stock Holding History

First Command Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-490	Closed	-$14K	–	369
2019 Q4	$14K	Buy	+490	New	+$13.6K	0.01%	289

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

First Command Bank's NVO Position: Q1 2020 in Review

First Command Bank sold out of Novo Nordisk (NVO) in Q1 2020, closing a stake of 490 shares — an estimated $14K sold.

First Command Bank first reported a position in NVO in Q4 2019 and held it in 1 quarter. The position peaked at $14K in Q4 2019. 644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.

First Command Bank reported no remaining Novo Nordisk position as of Q1 2020 after selling out during the quarter.
First Command Bank sold 490 Novo Nordisk shares in Q1 2020, an estimated $14K.
First Command Bank first reported a position in Novo Nordisk in Q4 2019 and held it in 1 quarter.
First Command Bank's Novo Nordisk position peaked at $14K in Q4 2019.
644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.

Based on First Command Bank's 13F filing for Q1 2020, filed 20 Apr 2020.